发明名称 RAPIDLY DISINTEGRATING SOLID ORAL DOSAGE FORM
摘要 <P>PROBLEM TO BE SOLVED: To provide a rapidly disintegrating or soluble solid oral dosage form containing a poorly soluble nanoparticulate active ingredient. <P>SOLUTION: Disclosed is a formulation wherein a rapidly disintegrating nanoparticulate solid oral dosage form formulation containing a poorly soluble active ingredient having an effective average particle size of less than about 2,000 nm before being included in the dosage form and at least one surface stabilizer to be adsorbed on the surface of the active ingredient is present within a solid dosage form matrix containing a water-soluble or water-dispersible excipient selected from the group consisting of sugar, sugar alcohol, starch, a natural rubber, a natural polymer, a synthetic derivative of a natural polymer, a synthetic polymer, and a mixture thereof. <P>COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2011037876(A) 申请公布日期 2011.02.24
申请号 JP20100227452 申请日期 2010.10.07
申请人 ELAN PHARMA INTERNATL LTD 发明人 JAIN RAJEEV A;RUDDY STEPHEN B;CUMMING KENNETH IAIN;CLANCY MAURICE JOSEPH ANTHONY;CODD JANET ELIZABETH
分类号 A61K47/10;A61K47/38;A61K9/00;A61K9/16;A61K9/19;A61K9/20;A61K9/26;A61K31/192;A61K31/4422;A61K31/64;A61K45/00;A61K47/26;A61K47/32;A61K47/36;A61K47/42;A61K47/46;A61P3/10;A61P9/10;A61P9/12;A61P29/00 主分类号 A61K47/10
代理机构 代理人
主权项
地址